VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.600
0.00 (0.00%)
At close: Nov 4, 2024, 4:00 PM
0.606
+0.006 (1.00%)
After-hours: Nov 4, 2024, 7:02 PM EST
VolitionRx Revenue
VolitionRx had revenue of $395.80K in the quarter ending June 30, 2024, with 82.98% growth. This brings the company's revenue in the last twelve months to $976.52K, up 88.32% year-over-year. In the year 2023, VolitionRx had annual revenue of $775.30K with 153.04% growth.
Revenue (ttm)
$976.52K
Revenue Growth
+88.32%
P/S Ratio
49.52
Revenue / Employee
$8,877
Employees
110
Market Cap
55.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 775.30K | 468.91K | 153.04% |
Dec 31, 2022 | 306.39K | 216.36K | 240.30% |
Dec 31, 2021 | 90.04K | 76.60K | 570.25% |
Dec 31, 2020 | 13.43K | -3.66K | -21.43% |
Dec 31, 2019 | 17.10K | - | - |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Theratechnologies | 84.32M |
DIH Holding US | 67.62M |
Qilian International Holding Group | 29.87M |
Shattuck Labs | 4.12M |
Singular Genomics Systems | 2.72M |
Pheton Holdings | 572.29K |
Actinium Pharmaceuticals | 81.00K |
VNRX News
- 4 days ago - Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating - PRNewsWire
- 26 days ago - Volition to share new 'NETs in sepsis management' data insights at upcoming webinar - PRNewsWire
- 4 weeks ago - Volition hosts NETs in sepsis management symposium at ESICM Lives 2024 - PRNewsWire
- 5 weeks ago - Volition Appoints Dr. Ethel Rubin as an Independent Director - PRNewsWire
- 7 weeks ago - Volition Hosts KOL Roundtable on Sepsis - PRNewsWire
- 2 months ago - VolitionRx Limited (VNRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update - PRNewsWire
- 3 months ago - VolitionRx Announces Pricing of up to $21.5 Million Registered Direct Offering - PRNewsWire